0001628945-22-000150.txt : 20220929
0001628945-22-000150.hdr.sgml : 20220929
20220929191504
ACCESSION NUMBER: 0001628945-22-000150
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220927
FILED AS OF DATE: 20220929
DATE AS OF CHANGE: 20220929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sever Clint
CENTRAL INDEX KEY: 0001868945
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40824
FILM NUMBER: 221281808
MAIL ADDRESS:
STREET 1: C/O CUE HEALTH INC.
STREET 2: 4980 CARROLL CANYON RD. SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Health Inc.
CENTRAL INDEX KEY: 0001628945
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4980 CARROLL CANYON ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 412-8151
MAIL ADDRESS:
STREET 1: 4980 CARROLL CANYON ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Cue Inc.
DATE OF NAME CHANGE: 20141223
FORMER COMPANY:
FORMER CONFORMED NAME: Cue, Inc.
DATE OF NAME CHANGE: 20141222
4
1
wf-form4_166449328317916.xml
FORM 4
X0306
4
2022-09-27
0
0001628945
Cue Health Inc.
HLTH
0001868945
Sever Clint
C/O CUE HEALTH INC.
4980 CARROLL CANYON RD. SUITE 100
SAN DIEGO
CA
92121
0
1
0
0
Chief Product Officer
Common Stock
2022-09-27
4
M
0
19215
0.20
A
3969495
D
Common Stock
2022-09-27
4
S
0
19215
2.94
D
3950280
D
Common Stock
2022-09-28
4
M
0
34113
0.20
A
3984393
D
Common Stock
2022-09-28
4
S
0
34113
3.07
D
3950280
D
Common Stock
2022-09-29
4
M
0
19290
0.20
A
3969570
D
Common Stock
2022-09-29
4
S
0
19290
2.94
D
3950280
D
Employee Stock Option (right to buy)
0.2
2022-09-27
4
M
0
19215
0
D
2022-12-31
Common Stock
19215.0
460825
D
Employee Stock Option (right to buy)
0.2
2022-09-28
4
M
0
34113
0
D
2022-12-31
Common Stock
34113.0
426712
D
Employee Stock Option (right to buy)
0.2
2022-09-29
4
M
0
19290
0
D
2022-12-31
Common Stock
19290.0
407422
D
The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.88 to $3.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.94 to $3.135, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.89 to $3.02, inclusive.
Shares subject to the option are fully vested and immediately exercisable.
/s/ Erica Palsis, Attorney-in-Fact for Clint Sever
2022-09-29